FEED TEST
feed should appear below....
Xenon Joins the Russell 3000® and Russell 2000® Indexes
2025-06-27
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-06-26
Xenon Announces Appointment of Darren Cline as Chief Commercial Officer
2025-06-24
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
2025-06-03